We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Burning Rock Biotech Ltd | LSE:BNR | London | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.35 | 0 | 01:00:00 |
TIDMBNR
RNS Number : 3390N
Blenheim Natural Resources PLC
08 August 2017
8 August 2017
BLENHEIM NATURAL RESOURCES PLC
("Blenheim" or the "Company")
Lapse of option to acquire an equity interest in TAM Mining Limited
Blenheim advises that its option to subscribe for 7.5% of the share capital of TAM Mining Limited ("TAM"), announced on 8 August 2016, has lapsed.
The Company held an option, exercisable by Blenheim within a period of 6 months of (i) TAM obtaining an NI 43-101 compliant resource statement; or (ii) within 12 months of the date of the agreement, whichever was sooner, to acquire, subject to certain conditions, 7.5% of the fully diluted issued share capital of TAM, by assisting TAM to raise a minimum of US$5 million. The conditions have not all been satisfied in full and the option has therefore lapsed.
Blenheim's Chairman, Chris Ells, commented: "We are disappointed that the conditions to exercise the option were not fully satisfied within the option period. We continue to believe that the West Lumba project is highly promising and we will consider other ways to invest, whilst also reviewing other investment opportunities."
Ends
For further information please contact:
Blenheim Natural +44 (0) 1622 Chris Ells Resources Plc 844601 Colin Aaronson/Jamie Barklem/ Daniel Grant Thornton UK +44 (0) 20 Bush LLP 7383 5100 +44 (0)1483 Nick Emerson SI Capital Ltd 413500 Lucy Williams / Peterhouse Corporate +44 (0) 20 Duncan Vasey Finance Limited 7469 0932 Cornhill Capital +44 (0) 20 Nick Bealer Limited 7710 9610
The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FURLFFFITRIDIID
(END) Dow Jones Newswires
August 08, 2017 02:00 ET (06:00 GMT)
1 Year Burning Rock Biotech Chart |
1 Month Burning Rock Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions